Gerresheimer confirms outlook for 2013

Düsseldorf (ots) -

- Cross reference: Full press release including tables is
available at http://www.presseportal.de/dokumente abrufbar -

- Third-quarter revenues up 1.8% (+4.5% excluding exchange rate
effects), to EUR 316.9m
- Adjusted EBITDA reaches EUR 61.6m (prior-year quarter: EUR
61.6m)
- Net income climbs 31.8% to EUR 19.5m (prior-year quarter: EUR
14.8m)
- Earnings per share rise by 32.1% to EUR 0.57 (prior-year
quarter: EUR 0.43)
- Guidance for financial year 2013 confirmed
- Gerresheimer to adopt new structure from financial year 2014

Gerresheimer AG, one of the leading partners to the pharma and
healthcare industry worldwide, increased both revenues and net income
in the third quarter. "Our business performance continues to be
strong and very stable. As before, we expect revenue growth of 5% to
6% on a like-for-like exchange rate basis for financial year 2013.
That is the outcome of our rigorous strategic focus on pharmaceutical
markets in Europe, North America and the fast growing emerging
markets," said Uwe Röhrhoff, CEO of Gerresheimer AG.

Gerresheimer increased revenues in the third quarter of financial
year 2013 (with a financial year from December 1 to November 30) by
1.8% to EUR 316.9m. Excluding exchange rate effects, revenues grew by
a substantial 4.5% compared with the prior-year quarter. The
pharmaceutical glass and pharmaceutical plastic systems businesses
contributed notably to this growth. The Company generated adjusted
EBITDA of EUR 61.6m in the third quarter of 2013, exactly the same
figure as a year earlier. The adjusted EBITDA margin was 19.4%,
slightly below the 19.8% margin in the prior-year period. This
reflected the slightly increased but still low margin in the Tubular
Glass Division.

Net income for the third quarter came to EUR 19.5m, 31.8% more
than the prior-year quarter (EUR 14.8m). Earnings per share were EUR
0.14 up on the prior-year quarter, at EUR 0.57. Gerresheimer's
capital expenditure in the third quarter of 2013 was EUR 20.7m
(prior-year quarter: EUR 23.3m).

Outlook

In future, Gerresheimer AG plans to gear its structure more
closely than ever to market needs. From the beginning of the new
financial year on December 1, 2013, the Company will be managed
through three divisions: Plastics and Devices, Primary Packaging
Glass and Life Science Research. "In realigning our divisions, we are
adopting a leaner management structure and focusing our organization
more tightly around customer needs," Uwe Röhrhoff said.

The divisions will continue to operate under their existing
structure until November 30, 2013. Stefan Grote, Member of the
Management Board with responsibility for Tubular Glass and Life
Science Research Divisions, left the Company by mutual agreement as
of September 30, 2013.

From today's perspective, the Company projects that the
combination, primarily of operating and administrative management
functions, is likely to involve costs in the mid-single-digit
millions of euros. The resulting annual savings are estimated at
about 50% of this cost figure. In addition, the Company plans to
assess their portfolio to figure out whether a few individual assets
are to be written off in full. That may lead to a non-cash impairment
in the order of around EUR 5m, excluding exchange rate effects.

For financial year 2013, Gerresheimer continues to expect revenue
growth of 5% to 6% at constant exchange rates. As before, the Company
anticipates adjusted EBITDA in a range of between EUR 245m and EUR
250m at constant exchange rates. Largely due to the healthy growth
prospects in pharmaceutical systems, capital expenditure in financial
year 2013 will represent some 9% to 10% of the revenues at constant
exchange rates.

Press Contact:
Gerresheimer AG
Jens Kürten
Director Corporate Communication & Marketing
Phone +49 211 6181-250
Fax +49 211 6181-241
E-Mail j.kuerten@gerresheimer.com
Website: www.gerresheimer.com